Simple minimally-invasive automatic antidote delivery device (A2D2) towards closed-loop reversal of opioid overdose
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Dhowan, Bahar | - |
dc.contributor.author | Lim, Jongcheon | - |
dc.contributor.author | MacLean, Michael D | - |
dc.contributor.author | Berman, Alycia G | - |
dc.contributor.author | Kim, Min Ku | - |
dc.contributor.author | Yang, Qi | - |
dc.contributor.author | Linnes, Jacqueline | - |
dc.contributor.author | Lee, Chi Hwan | - |
dc.contributor.author | Goergen, Craig J | - |
dc.contributor.author | Lee, Hyowon | - |
dc.date.accessioned | 2023-08-22T03:02:41Z | - |
dc.date.available | 2023-08-22T03:02:41Z | - |
dc.date.created | 2023-07-21 | - |
dc.date.issued | 2019-07 | - |
dc.identifier.issn | 0168-3659 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/189436 | - |
dc.description.abstract | With approximately 48,000 attributed deaths in 2017, the opioid overdose is now the leading cause of death amongst Americans under the age of 50. The overdose process can be interrupted by the administration of naloxone, a safe and effective opiate antagonist that can reverse the effects of overdose and minimizing the delay in administering the antidote is critical in preventing permanent damage to patients. A closed-loop implantable drug delivery system is an ideal solution to minimize the response time, however, they often feature complex designs that are expensive to fabricate and require a more invasive surgical implantation. Here we propose a simple, low-cost, minimally-invasive automatic antidote delivery device (A2D2) that can administer a large dose of naloxone upon detection of overdose-induced respiratory failure. The subcutaneously placed device can be activated using an externally applied time varying magnetic field from a wearable device. Using a custom magnetic field generator, we were able to release the drug within 10 s. Our bench-top evaluation showed that A2D2 can release 1.9 mg of powdered drug within 60 s and up to 8.8 mg in 600 s. We also performed in vivo evaluation to demonstrate rapid drug releasing capability in the subcutaneous space of mice. However, we saw a small amount of leakage (1.75% of payload) over the course of 1000 h of simulated implantation. Thus, additional research is needed to verify the long term stability of our device and to demonstrate the closed-loop release mechanism to revive overdosed animals. Nevertheless, our preliminary results show the potential of using a simple, low-cost, subcutaneous device for emergency drug delivery application. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCIENCE BV | - |
dc.title | Simple minimally-invasive automatic antidote delivery device (A2D2) towards closed-loop reversal of opioid overdose | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Min Ku | - |
dc.identifier.doi | 10.1016/j.jconrel.2019.05.041 | - |
dc.identifier.scopusid | 2-s2.0-85066928988 | - |
dc.identifier.wosid | 000474822700012 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CONTROLLED RELEASE, v.306, pp.130 - 137 | - |
dc.relation.isPartOf | JOURNAL OF CONTROLLED RELEASE | - |
dc.citation.title | JOURNAL OF CONTROLLED RELEASE | - |
dc.citation.volume | 306 | - |
dc.citation.startPage | 130 | - |
dc.citation.endPage | 137 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | CONTROLLED-RELEASE | - |
dc.subject.keywordPlus | NALOXONE | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordPlus | EPIDEMIC | - |
dc.subject.keywordPlus | IMPLANT | - |
dc.subject.keywordPlus | SKIN | - |
dc.subject.keywordAuthor | Drug delivery system | - |
dc.subject.keywordAuthor | Naloxone delivery | - |
dc.subject.keywordAuthor | Opioid overdose | - |
dc.subject.keywordAuthor | Emergency drug delivery | - |
dc.subject.keywordAuthor | Automated | - |
dc.subject.keywordAuthor | Overdose prevention | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0168365919303050?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.